Do calcium antagonists cause cancer? [1]

Lancet

Volumn 348, Issue 9026, 1996, Pages 541-542

  Kaplan, N M ^a   Pahor, M ^a   Guralnik, J M ^a   Salive, M E ^a   Corti, M C ^a   Havlik, R J ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; RESERPINE;

BREAST CANCER; CANCER; DRUG SAFETY; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LETTER; METHODOLOGY; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

EID: 0029736966     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)24034-6     Document Type: Letter

References (5)

1. M Pahor JM Guralnik ME Salive Do calcium channel blockers increase the risk of cancer? Am JHypertens 9 1996 695 699
2. M Pahor JM Guralnik MC Corti Long-term survival and use of antihypertensive medications in older persons J Am Geriatr Soc 43 1995 1191 1197
3. M Pahor JM Guralnik CD Furberg Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 6 7 years old Lancet 347 1996 1061 1065
4. BM Psaty SR Heckbert TD Koepsell The risk of myocardial infarction associated with antihypertensive drug therapies JAMA 274 1995 620 625
5. LC Mayes RI Horwitz AR Feinstein A collection of 56 topics with contradictory results in case-control research Int J Epidemiol 17 1988 680 685